Microrna 132-3p is upregulated in laron syndrome patients and controls longevity gene expression

Danielle Yaron-Saminsky*, Karthik Nagaraj, Rive Sarfstein, Zvi Laron, Metsada Pasmanik-Chor, Haim Werner

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


The growth hormone (GH)–insulin-like growth factor-1 (IGF1) endocrine axis is a central player in normal growth and metabolism as well as in a number of pathologies, including cancer. The GH–IGF1 hormonal system, in addition, has emerged as a major determinant of lifespan and healthspan. Laron syndrome (LS), the best characterized entity under the spectrum of the congenital IGF1 deficiencies, results from mutation of the GH receptor (GHR) gene, leading to dwarfism, obesity and other defects. Consistent with the key role of IGF1 in cellular proliferation, epidemiological studies have shown that LS patients are protected from cancer development. While reduced expression of components of the GH-IGF1 axis is associated with enhanced longevity in animal models, it is still unknown whether LS is associated with an increased lifespan. MicroRNAs (miRs) are endogenous short non-coding RNAs that regulate the expression of complementary mRNAs. While a number of miRs involved in the regulation of IGF components have been identified, no previous studies have investigated the differential expression of miRs in congenital IGF1 deficiencies. The present study was aimed at identifying miRs that are differentially expressed in LS and that might account for the phenotypic features of LS patients, including longevity. Our genomic analyses provide evidence that miR-132-3p was highly expressed in LS. In addition, we identified SIRT1, a mem-ber of the sirtuin family of histone deacetylases, as a target for negative regulation by miR-132-3p. The data was consistent with the notion that low concentrations of IGF1 in LS lead to elevated miR-132-3p levels, with ensuing reduction in SIRT1 gene expression. The impact of the IGF1-miR-132-3p-SIRT1 loop on aging merits further investigation.

Original languageEnglish
Article number11861
JournalInternational Journal of Molecular Sciences
Issue number21
StatePublished - 1 Nov 2021


FundersFunder number
Israel Science Foundation


    • Congenital IGF1 deficiency
    • Insulin-like growth factor-1 (IGF1)
    • Laron syndrome
    • Longevity
    • MicroRNA-132-3p
    • SIRT1


    Dive into the research topics of 'Microrna 132-3p is upregulated in laron syndrome patients and controls longevity gene expression'. Together they form a unique fingerprint.

    Cite this